MM1OA-S03:A Randomized Phase II Trial of ASTX727 and Venetoclax Compared with ASTX727, Venetoclax, and Enasidenib for Newly Diagnosed Older Adults with IDH2 Mutant Acute Myeloid Leukemia: A MyeloMATCH Substudy
CCTG-BR38:Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer - A Randomized Phase 3 Trial
NRG-CC014: Radiation Therapy for High-Risk Asymptomatic Bone Metastases: A Pragmatic Multicenter Randomized Phase 3 Clinical Trial (PREEMPT)
Research Base Meetings
Alliance Spring Meeting: April 30 - May 3, 2025 - Chicago, IL
SWOG Spring Meeting: May 1, 2025 - May 3, 2025 - San Francisco, CA
ECOG-ACRIN Spring Meeting: May 13-15, 2025 - Tampa, FL
NRG Summer Meeting: July 24-26, 2025 - Washington, DC
Accruals, Biospecimens, & Special Entries
Under-Represented Populations
CCDR Corner
EAQ221CD: Improving Medication Adherence in Metastatic Breast Cancer Using a Connected Customized Treatment Platform (CONCURxP)
BSSF recently began accruing to this important study that aims to find out if text message reminders and alerts can make it easier for patients to stick to the medication schedule for CDK4/6 inhibitors (Palbociclib, Ribociclib, or Abemaciclib). Way to go, April!
All About AYAs
Monthly NCORP Administrator Webinar
Bon Secours St. Francis received recognition at the NCORP Administrator webinar earlier held on March 26th for accruing to WF-2201. Keep up the good work!
Do you have any staff you would like highlighted in The Connector?
Please submit it by the 15th of the month to Jetta: Jturner@gibbscc.org
